# In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects

> **NCT05429775** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT05429775
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-26
- **Primary completion:** 2019-01-29
- **Final completion:** 2019-01-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429775, "In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05429775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*